newsfilter
← Latest News
GlobeNewswire·

Avid Bioservices Reports Financial Results for Third Quarter Ended January 31, 2023, and Recent Developments

-- Recorded Third Quarter Revenue of $38.0 Million, a 21% Increase Compared to Prior Year Quarter -- -- Signed $67 Million in Net New Business Orders Resulting in a Backlog of $176 million, an Increase of 26%